The Pulmonary Fibrosis Foundation (PFF), the nation's leading pulmonary fibrosis (PF) research, education and advocacy ...

London-based GSK is crossing the pond to form a new lung disease research collaboration with Boston scientists. | ...

AN INSIGHTFUL session on the future of lung transplantation presented at this year’s European Respiratory Society (ERS) ...

A higher abundance of monocyte-derived alveolar macrophages significantly correlated with worse lung fibrosis in RPRA ...

IPF is a chronic, progressive lung disease marked by lung tissue thickening and scarring, leading to reduced lung function. It is a specific type of interstitial lung disease, which includes various ...

Progressive pulmonary fibrosis (PPF) is an increasingly recognised condition, defined in 2022 to address the progression of ...

Anti-fibrotic therapies, like Ofev and Genentech's Esbriet (pirfenidone), work by slowing the rate of fibrosis and are ...

A WOMAN tied the knot with her husband in hospital just 48 hours before he died — and has shared her story to raise awareness of his disease. Mike Reynolds, 51, married his partner of eight years ...

GSK is pumping £50 million (about $65 million) into a five-year collaboration with the University of Cambridge and Cambridge ...

Researchers from the Center for Regenerative Medicine (CReM) at Boston University and (BMC) have announced a new collaboration with the global biopharma company GSK to advance innovative research ...

When you can't breathe, the world stops,' a retired HPD officer said of his near-death battle with COVID-19. Fortunately, his world didn't stop; he discovered a new sense of purpose as a health ...

Emily Pink, 21, has cystic fibrosis, a rare genetic disorder that causes a build-up of sticky mucus in her lungs and ...